Salta al contenuto principale

sulfatase modifying factor 1

L SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Scelte video per Genes
Video library

Normal function

L SUMF1 gene provides instructions for making an enzyme called formylglycine-generating enzyme (FGE). This enzyme is found in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport. The FGE enzyme modifies other enzymes called sulfatases, which aid in breaking down substances that contain chemical groups known as sulfates. These substances include a variety of sugars, fats, and hormones. Specifically, FGE converts a protein building block (amino acid) within sulfatases called cysteine into a molecule called C-alpha-formylglycine.

Conditions referring to this gene or chromosome

Altri nomi

AAPA3037

C-alpha-formylglycine-generating enzyme 1

FGE

FGly-generating enzyme

sulfatase-modifying factor 1

UNQ3037

Related patient information and medicines

Farmaci antireumatici modificanti la malattia

Patient information leaflet

Farmaci antireumatici modificanti la malattia

Farmaci antireumatici modificanti la malattia (DMARDs) are medicines that are normally prescribed as soon as rheumatoid artrite (RA) is diagnosed, in order to reduce damage to the joints. Farmaci antireumatici modificanti la malattia (DMARDs) are a group of medicines that are used to ease the sintomi di artrite reumatoide (RA) Rheumatoid artrite and reduce.

Artrite reattiva

Patient information leaflet

Artrite reattiva

... If symptoms continue for more than a few months, or if other treatments have not worked, you may be advised to take a disease-modifying medicine Disease-modifying antirheumatic drugs. These are sometimes called disease-modifying antirheumatic drugs (DMARDs). This aims to reduce the damaging effect on the joints. There are several - for.

Artrite psoriasica

Patient information leaflet

Artrite psoriasica

Artrite psoriasica is a particular type di artrite that develops in some people who also have psoriasis. Arthritis Arthritis means inflammation of the joints. They work by blocking the effects of chemicals involved in causing joint inflammation. Sulfasalazine Sulfasalazine and methotrexate Methotrexate are the most commonly used DMARDs for.

Artrite reumatoide

Patient information leaflet

Artrite reumatoide

Rheumatoid arthritis causes inflammation, pain, and swelling of joints. Rheumatoid artrite treatment Standards of care hai l'emocromatosi should expect The National Institute for Health and Care Excellence (NICE) has published quality standards on the standard of care that should be offered to every adult over 16 who has RA. ...Ds) Disease-modifyingDMARDs.

Colangite sclerosante primitiva

Patient information leaflet

Colangite sclerosante primitiva

Primaria colangite sclerosante is an uncommon condition affecting the bile ducts and liver. Inflammation and scarring of the bile ducts can lead to liver damage and cirrhosis - a condition where normal liver tissue is replaced by scar tissue (fibrosis). Different treatments are available to control symptoms that may develop and also to manage ....

Artrite idiopatica giovanile

Patient information leaflet

Artrite idiopatica giovanile

So, artrite idiopatica giovanile (AIG) is a condition in which this infiammazione of one or more joints begins in children under the age of 16 years. ...e used to help reduce the effects of the disease Disease-modifyingDMARDs used for JIA include: Methotrexate Methotrexate Sulfasalazine Sulfasalazine Leflunomide Leflunomide tablets for arthritis.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Ago 2020 | Ultima versione
  • 1 Jul 2014 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.